Adtalem Global Education (NYSE:CVSA) CFO Sells $1,262,100.00 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 10,000 shares of the company’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $126.21, for a total value of $1,262,100.00. Following the transaction, the chief financial officer owned 55,806 shares in the company, valued at $7,043,275.26. This trade represents a 15.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 1.5%

NYSE:CVSA traded down $1.96 during trading hours on Tuesday, reaching $128.28. 239,676 shares of the stock were exchanged, compared to its average volume of 392,864. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a 50-day simple moving average of $111.84. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The stock has a market cap of $4.37 billion, a P/E ratio of 19.98, a price-to-earnings-growth ratio of 1.11 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company had revenue of $487.03 million for the quarter. During the same quarter last year, the company earned $1.92 earnings per share. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, research analysts forecast that Adtalem Global Education Inc. will post 8.05 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have commented on CVSA. Barrington Research restated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research note on Friday, April 17th. Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings initiated coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Truist Financial upped their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday. Finally, Wall Street Zen lowered Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.